Methyl sulfonyl methane-containing composition for preventing or alleviating obesity, fatty liver, and diabetes

Abstract

The present invention pertains to a methyl sulfonyl methane-containing composition for preventing or alleviating obesity, fatty liver, and diabetes. An MSM (Methyl Sulfonyl Methane: Dimethyl Sulfone)-containing composition according to the present invention, which contains 75-85 wt% of MSM, 0.5-2 wt% of Vitamin B6 hydrochloride, 0.01-1 wt% of folic acid, 2-8 wt% of galactooligosaccharide, 10-18 wt% of rice-fermented magnesium, and 0.5-3 wt% of Vitamin C, not only can prevent and treat obesity by reducing the size of fat cells and inhibiting differentiation of mature fat cells, but also lowerstriglyceride and the total cholesterol concentration in the liver, thus having a fatty liver preventing effect, and also reduces the concentration of insulin-like growth factor, thus also being effective for diabetes. Therefore, the MSM-containing composition is expected to be useful as a pharmaceutical composition and food composition for preventing and alleviating obesity, fatty liver, and diabetes.

Description

technical field [0001] The present invention relates to a composition for preventing or improving obesity, fatty liver and diabetes containing methylsulfonylmethane. Background technique [0002] Visceral obesity is increasing due to changes in the living environment such as eating habits, and the onset of metabolic syndrome (metabolic syndrome) accompanied by fatty liver, lipid metabolism disorder, diabetes, insulin resistance, hypertension, etc. is becoming a social problem . These diseases increase the risk of each other and are common diseases associated with metabolic changes in multiple organisms, such as aging, stress and decreased immune function. [0003] Fatty liver is considered to be caused mainly by obesity and diabetes caused by chronic alcoholism and overeating. In addition, it can be caused by taking highly toxic drugs, taking antibiotics by mistake during pregnancy, and when children suffer from febrile infectious diseases. Fatty liver occurs when aspirin ...

AI Technical Summary

Problems solved by technology

[0016] However, although strict blood sugar regulation can prevent or delay the occurrence of diabetic complications, medicinal materials effective in the treatment of type 2 diabetes have many shortcomings in preventing strict blood sugar regulation or diabetic complications, so the development of new therapeutic agents is required

Images